By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merz Pharma Group 

Eckenheimer Landstra├če 100

Frankfurt am Main    D-60318  Germany
Phone: 49-69-1503-0 Fax: 49-69-1503-200



Company News
Merz Pharma Group Announces European Approval Of Bocouture For The Treatment Of Upper Facial Lines 3/17/2016 10:07:02 AM
Merz Pharma Group North America Announces Internal Promotions within its North American Leadership Team 9/30/2013 10:29:17 AM
Merz Pharma Group Acquires Swiss Dermatology Company Neocutis S.A. 7/31/2013 10:02:44 AM
Merz Pharma Group Declines to Raise Bid for Obagi Medical Products, Inc. (OMPI), Yielding to Valeant Pharmaceuticals International (VRX) 4/8/2013 7:53:27 AM
Merz Pharma Group Offers $383.5 Million for Obagi Medical Products, Inc. (OMPI), Tops Deal Announced Last Month With Valeant Pharmaceuticals International (VRX) 4/2/2013 7:32:19 AM
Merz Pharma Group Announces Promotion of Hyunna Coelho to Vice President, Commercial Excellence 10/1/2012 11:22:33 AM
Merz Pharma Group Announces the Acquisition of CUVPOSA® (glycopyrrolate) Oral Solution, First and Only FDA-Approved Treatment for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions 8/27/2012 10:52:14 AM
The Merz Pharma Group Appoints William D. Humphries as New North American Chief Executive Officer 3/14/2012 7:39:19 AM
Merz Pharma Group to Complete Acquisition of BioForm Medical, Inc. 2/19/2010 9:54:05 AM
Merz Pharma Group Successfully Completes BioForm Medical, Inc. Tender Offer with over 94 Percent of Shares Tendered 2/16/2010 10:11:24 AM